1,296
Views
126
CrossRef citations to date
0
Altmetric
Research Article

Risk assessment of engineered nanomaterials: a review of available data and approaches from a regulatory perspective

, , &
Pages 880-898 | Received 03 Mar 2011, Accepted 23 Aug 2011, Published online: 09 Jan 2012

References

  • Ahlers J, Stock F, Werschkun B. 2008. Integrated testing and intelligent assessment- new challenges under REACH. Environ Sci Pollut Res 15:565–572.
  • Bassan A, Worth A. 2008. The integrated use of models for the properties and effects of chemicals by means of a structured workflow. QSAR Comb Sci 27:6–20.
  • Bergamaschi E. 2009. Occupational exposure to nanomaterials: present knowledge and future development. Nanotoxicology 3:194–201.
  • Boxall ABA, Chaudhry Q, Jones A, Jefferson B, Watts CD. 2008. Current and future predicted environmental exposure to engineered nanoparticles. Central Science Laboratory York for the Department of the Environment and Rural Affairs, Sand Hutton, UK.
  • British Standards Institution (BSI). 2007. PAS136 Terminology for nanomaterials. 2011 February; Accessed from the website: http://www.bsiglobal.com.
  • Burello E, Worth AP. 2010. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology 0:1–8.
  • Christensen FM, Sokull-Kluettgen B, Sintes JR. 2010. Towards REACH guidance on nanomaterials. NanoImpactNet conference; 2010 March 9–12; Lausanne.
  • Clark K, Van Tongeren M, Rashid S, Brouwer D, Christensen F, Nowack B, 2011. NANEX: Development of exposure scenarios for manufactured nanomaterials-scientific integration and gap analysis. 2011 July; Accessed from the website: http://nanex-project.eu/index.php/public-documents/cat_view/43-dissemination-reports/74-wps-reports.
  • Council of Canadian Academies. 2008. Small is different: a science perspective on the regulatory challenges of the nanoscale. 2011 February; Accessed from the website: http://www.scienceadvice.ca/uploads/eng/assessments%20and%20publications%20and%20news%20releases/nano/(2008_07_10)_report_on_nanotechnology.pdf.
  • Environmental Defense and DuPont. 2007. Nano risk framework. 2011 February; Accessed from the website: http://nanoriskframework.com/page.cfm?tagID=1095.
  • ECHA. 2007a. Guidance for the implementation of REACH: guidance on information requirements and chemical safety assessment. Part A: introduction to the guidance document. 2011 February; Accessed from the website: http://guidance.echa.europa.eu/guidance_en.htm.
  • ECHA. 2007b. Guidance for the implementation of REACH: guidance on information requirements and chemical safety assessment. Part B: hazard assessment. 2011 February; Accessed from the website: http://guidance.echa.europa.eu/guidance_en.htm.
  • ECHA. 2007c. Guidance for the implementation of REACH: guidance on information requirements and chemical safety assessment. Part D: exposure scenario building. 2011 February; Accessed from the website: http://guidance.echa.europa.eu/guidance_en.htm.
  • European Commission. 2008. Follow-up to the 6th meeting of the REACH competent authorities for the implementation of Regulation (EC) 1907/2006 (REACH): Nanomaterials in REACH. 2011 February; Accessed from the website: http://ec.europa.eu/environment/chemicals/reach/pdf/nanomaterials.pdf.
  • Fransman W, Verbist K, Stuurman B, Vink S, Heussen H, Brouwer D, van Niftrik M. 2010. Stoffenmanager nano 1.0: an online control banding tool for the prioritization of risks related to working with manufactured nano objects. Nanosafe 2010 conference in Grenoble, France.
  • Gosens I. 2011. RE: In vitro-in vivo extrapolation in the risk assessment of engineered nanomaterials. Type to Hristozov, D.
  • Gottschalk F, Scholz RW, Nowack B. 2010b. Probabilistic material flow modeling for assessing the environmental exposure to compounds: Methodology and an application to engineered nano-TiO2 particles. Environ Model Softw 25:320–332.
  • Gottschalk F, Sonderer T, Scholz RW, Nowack B. 2009. Modeled environmental concentrations of engineered nanomaterials (TiO2, ZnO, Ag, CNT, fullerenes) for different regions. Environ Sci Technol 43:9216–9222.
  • Gottschalk F, Sonderer T, Scholz RW, Nowack B. 2010a. Possibilities and limitations of modeling environmental exposure to engineered nanomaterials by probabilistic material flow analysis. Environ Tox Chem 29:1036–1048.
  • Grieger K, Baun A, Owen R. 2010. Redefining risk research priorities for nanomaterials. J Nanopar Res 12:383–392.
  • Grieger K, Linkov I, Hansen SF, Baun A. 2011. Environmental risk analysis for nanomaterials: Review and evaluation of frameworks. Nanotoxicology 0:1–17.
  • Greim H. 2009. Alternative methods to safety studies in experimental animals. Arch Toxicol 83:5–7.
  • Hansen SF. 2009. Regulation and risk assessment of nanomaterials – too little, too late? 2011 February; Accessed from the website: http://www2.er.dtu.dk/publications/fulltext/2009/ENV2009-069.pdf.
  • Hansen S, Michelson E, Kamper A, Borling P, Stuer-Lauridsen F, Baun A. 2008. Categorization framework to aid exposure assessment of nanomaterials in consumer products. Ecotoxicology 17:438–447.
  • Hansen SF, Larsen BH, Olsen SI, Baun A. 2007. Categorization framework to aid hazard identification of nanomaterials. Nanotoxicology 1:243–250.
  • Höck J, Epprecht T, Hofmann H, Höhner K, Krug H, Lorenz C, 2010. Guidelines on the Precautionary Matrix for synthetic nanomaterials. 2011 February; Accessed from the website: http://www.bag.admin.ch/themen/chemikalien/00228/00510/05626/index.html?lang=en.
  • Hristozov D, Malsch I. 2009. Hazards and risks of engineered nanoparticles for the environment and human health. Sustainability 1:1161–1194.
  • OECD. 2004. Description of selected key generic terms used in chemical hazard/risk assessment. 2011 February; Accessed from the website: http://www.who.int/ipcs/publications/methods/harmonization/en/terminol_part-I.pdf.
  • International Risk Governance Council (IRGC). 2006. White paper No. 2: nanotechnology risk governance. 2011 February; Accessed from the website: http://www.irgc.org/IMG/pdf/PB_nanoFINAL2_2_.pdf.
  • International Risk Governance Council. 2007. White paper No. 2: nanotechnology risk governance. 2011 December; Accessed from the website: http://www.irgc.org/IMG/pdf/PB_nanoFINAL2_2_.pdf.
  • Jaworska J, Gabbert S, Aldenberg T. 2010. Towards optimization of chemical testing under REACH: a Bayesian network approach to integrated testing strategies. Regul Toxicol Pharmacol 57:157–167.
  • Joint Research Center (JRC). 2004. Science in trade disputes related to potential risks: comparative case studies. Series EUR 21301 EN. 2011 February; Accessed from the website: http://www.oeaw.ac.at/ita/ebene5/HT_1271.pdf.
  • Kandlikar M, Ramachandran G, Maynard A, Murdock B, Toscano WA. 2006. Health risk assessment for nanoparticles: a case for using expert judgment. In: Maynard AD, Pui DYH, editors. Nanotechnology and occupational health. Dordrecht: Springer. pp 137–156.
  • Kandlikar M, Ramachandran G, Maynard A, Murdock B, Toscano WA. 2007. Health risk assessment for nanoparticles: a case for using expert judgment. In: Maynard AD, Pui DYH, editors. Nanotechnology and occupational health. Dordrecht: Springer. pp 137–156.
  • Kerr RA. 1996. Risk sssessment: a new way to ask the experts: rating radioactive waste risks. Science 274:913–914.
  • Lee HA, Leavens TL, Mason SE, Monteiro-Riviere NA, Riviere JE. 2008. Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model. Nano Lett 9:794–799.
  • Leeuwen C, Vermeire T. 2007. Risk assessment of chemicals: an introduction. 2nd ed. Dordrecht: Springer.
  • Liao C, Chiang Y, Chio C. 2008. Model-based assessment for human inhalation exposure risk to airborne nano/fine titanium dioxide particles. Sci Total Environ 407:165–177.
  • Linkov I, Satterstrom FK, Kiker G, Batchelor C, Bridges T, Ferguson E. 2006. From comparative risk assessment to multi-criteria decision analysis and adaptive management: recent developments and applications. Environ Int 32:1072–1093.
  • Linkov I, Steevens J, Adlakha-Hutcheon G, Bennett E, Chappell M, Colvin V, 2009. Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res 11:513–527.
  • Linkov I, Satterstrom F, Steevens J, Ferguson E, Pleus R. 2007. Multi-criteria decision analysis and environmental risk assessment for nanomaterials. J Nanopart Res 9:543–554.
  • Linkov I, Welle P, Loney D, Tkachuk A, Canis L, Kim JB, Bridges T. 2011. Use of multicriteria decision analysis to support weight of evidence evaluation. Risk Analysis 31:1211–1225.
  • Lux Research. 2006. The nanotech report 4th edition. 2011 February; Accessed from the website: https://portal.luxresearchinc.com/research/document_excerpt/2778.
  • Maynard AD. 2007. Nanotechnology: the next big thing, or much ado about nothing? Ann Occup Hyg 51:1–12.
  • Meng H, Xia T, George S, Nel AE. 2009. A predictive toxicological paradigm for the safety assessment of nanomaterials. ACS Nano 3:1620–1627.
  • Metcalfe C. 2009. SMARTEN: strategic management and assessment of risks and toxicity of engineered nanomaterials. In: Linkov I, Steevens J, editors. Nanomaterials: Risks and Benefits. 1st ed. Dordrecht: Springer. pp 95–109.
  • Morgan K. 2005. Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles. Risk Anal 25:1621–1635.
  • Mueller NC, Nowack B. 2008. Exposure modeling of engineered nanoparticles in the environment. Environ Sci Technol 42:4447–4453.
  • NanoSafer [Internet]. Copenhagen: Industriens Branchearbejsmiljøråd; 2011 Feb 22- [cited 2011 Feb 24]; Available from: http://nanosafer.i-bar.dk/.
  • Nielsen E, Ostergaard G, Larsen J. 2007. Toxicological risk assessment of chemicals: a practical guide. New York: Informa Healthcare.
  • Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839.
  • Organization for Economic Cooperation and Development (OECD). 1982. Decision of the council concerning the minimum pre-marketing set of data in the assessment of chemicals. 2011 February; Accessed from the website: http://www.oecd.org/document/47/0,3746,en_2649_37465_1817647_1_1_1_37465,00.html.
  • Pang C, Selck H, Rank J, Forbes V. 2010. The challenge to regulate manufactured nanomaterials under REACH. SETAC Europe 20th Annual Meeting in Seville, Spain.
  • Patton DE. 1993. The ABCs of risk assessment. EPA J 19:10–15.
  • Puzyn T, Gajewicz A, Leszczynska D, Leszczynski J. 2010. Nanomaterials-the Next Great Challenge for QSAR Modelers. In: Puzyn T, Leszczynski J, Cronin MT, editors. Recent Advances in QSAR Studies. Dordrecht: Springer. pp 383–409.
  • Riviere JE. 2009. Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. WIREs: Nanmed Nanobiotech 1:26–34.
  • Robichaud C, Tanzil D, Weilenmann U, Wiesner M. 2005. Relative risk analysis of several manufactured nanomaterials: an insurance industry context. Environ Sci Technol 39:8985–8994.
  • Royal Society and the Royal Academy of Engineering. 2004. Nanoscience and nanotechnologies: opportunities and uncertainties. 2011 February; Accessed from the website: http://www.nanotec.org.uk/finalReport.htm.
  • SCENIHR. 2005. Opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. 2011 February; Accessed from the website: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_003b.pdf.
  • SCENHIR. 2007. Opinion on the appropriateness of the risk assessment methodology in accordance with the Technical Guidance Documents for new and existing substances for assessing the risks of nanomaterials. 2011 February; Accessed from the website: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_010.pdf.
  • SCENHIR. 2009. Opinion on: Risk assessment of products of nanotechnologies. 2011 July; Accessed from the website: http://ec.europa.eu/health/archive/ph_risk/committees/04_scenihr/docs/scenihr_o_023.pdf.
  • Slob W. 2002. Dose-response modeling of continuous endpoints. Toxicol Sci 66:298–312.
  • Stone V, Hankin S, Aitken RJ, Achberger K, Baun A, Christensen F, 2010. Engineered nanoparticles: review of health and environmental safety (ENRHES). 2011 February; Accessed from the website: http://ihcp.jrc.ec.europa.eu/whats-new/enhres-final-report.
  • Tervonen T, Linkov I, Figueira J, Steevens J, Chappell M, Merad M. 2009. Risk-based classification system of nanomaterials. J Nanopart Res 11:757–766.
  • Tervonen T, Linkov I, Figueira J, Steevens J, Chappell M, Merad M. 2010. Risk-based classification system of nanomaterials. J Nanopart Res 11:757–766.
  • Tran L. 2011. Risk assessment of ENM: the results from FP7 ENPRA project. Symposium safety issues of nanomaterials along their lifecycle in Barcelona, Spain.
  • Tyshenko M, Krewski D. 2008. A risk management framework for the regulation of nanomaterials. Int J Nanotech 5:143–160.
  • Van Zwanenberg P, Millstone E. BSE: risk, science, and governance. Oxford: OUP; 2005.
  • Warheit DB. 2008. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101:183–185.
  • Wick P, Manser P, Limbach LK, Dettlaff-Weglikowska U, Krumeich F, Roth S, 2007. The degree and kind of agglomeration affect carbon nanotube cytotoxicity. Toxicol Lett 168:121–131.
  • Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, 2009. Nano-silver: a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3:109–138.
  • Zuin S, Micheletti C, Critto A, Pojana G, Johnston H, Stone V, 2010. Weight of evidence approach for the relative hazard ranking of nanomaterials. Nanotoxicology 0:1–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.